OpenAI launched ChatGPT Health and pushed offerings for hospitals and health systems, bringing its conversational LLM directly into clinical and administrative workflows. The company positioned the product as a tool for care navigation and workflows rather than a replacement for clinicians, while acknowledging potential regulatory implications for medical-grade uses. Hospitals and health systems will be able to integrate patient data and medical records into ChatGPT for personalized assistance; OpenAI framed this as enabling better access to information and operational support. Observers flagged that commercial deployments for professional use could attract more explicit FDA scrutiny, given prior agency interest in AI used for clinical decision-making. The move intensifies debate on governance, data privacy, and validation of large language models in regulated health settings. Providers weighing adoption will need documented safety cases, audit trails, and clarity on use boundaries to stay aligned with evolving regulatory expectations.